Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
Few studies investigated the effects of sublingual immunotherapy (SLIT) on the peripheral regulatory T cells (Tregs)/Th17 ratio.
Guardado en:
Autores principales: | Wang Jiarong, Qiu Liansheng, Chen Yimin, Chen Minyun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/678193c49dfe4f199d3fedc82e7434b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
por: Anne K. Ellis, et al.
Publicado: (2021) -
Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
por: Tankersley M, et al.
Publicado: (2021) -
Comparative Study between Intranasal Injection of Botulinum Toxin-A and Combined Intranasal Medical Treatment for Allergic Rhinitis
por: Nabil Sarhan, et al.
Publicado: (2020) -
Relationship between Saliva and Sublingual Immunotherapy
por: Aiko Oka, et al.
Publicado: (2021) -
Structural and functional characteristics of the T helpers 17 subpopulation in allergic diseases of the respiratory organs in children
por: E. V. Prosekova, et al.
Publicado: (2020)